Free. Unsubscribe any time.
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. filed 82 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 276 transactions and 1,144,479 shares. 82 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-10, came 2 days after the one before it (2026-07-08) and reports 1 transaction against 3 in the filing before it.
- The sales it reports total 2,111 shares, 27,889 fewer than the 30,000 in the filing before it.
- Its 82 plan statements rank 39th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 1 has more plan statements on file than it and 9 have fewer.
- Its 82 filings on file run from 2025-01-08 to 2026-07-10, and state 10 plan adoption dates, from 2023-12-06 to 2025-12-23.
Trades in Nuvalent, Inc. 276
- Balcom Alexandra — 2025-01-06 · S · 1,152 shares
- Balcom Alexandra — 2025-01-06 · S · 691 shares
- Balcom Alexandra — 2025-01-06 · S · 2,173 shares
- Miller Deborah Ann — 2025-01-06 · S · 850 shares
- Miller Deborah Ann — 2025-01-06 · S · 510 shares
- Miller Deborah Ann — 2025-01-06 · S · 1,604 shares
- Noci Darlene — 2025-01-06 · S · 1,152 shares
- Noci Darlene — 2025-01-06 · S · 691 shares
- Noci Darlene — 2025-01-06 · S · 2,173 shares
- Pelish Henry E. — 2025-01-06 · S · 712 shares
- Pelish Henry E. — 2025-01-06 · S · 428 shares
- Pelish Henry E. — 2025-01-06 · S · 1,343 shares
Adoption dates in Nuvalent, Inc. 10
- 2023-12-06 — stated in 14 filings
- 2023-12-21 — stated in 2 filings
- 2024-04-02 — stated in 10 filings
- 2024-11-01 — stated in 6 filings
- 2024-11-18 — stated in 29 filings
- 2024-11-20 — stated in 2 filings
- 2024-12-12 — stated in 7 filings
- 2025-12-04 — stated in 5 filings
- 2025-12-11 — stated in 2 filings
- 2025-12-23 — stated in 5 filings
Results prints in Nuvalent, Inc. 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-01-14
- 2026-02-26
- 2026-05-07
Trades before a print in Nuvalent, Inc. 33
- 0 days before the 2025-08-07 print — 2025-08-07 · S · Pelish Henry E. · 5,500 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 700 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 1,273 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 500 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 600 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 2,121 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 3,733 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 3,491 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Miller Deborah Ann · 9,382 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Noci Darlene · 57 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Noci Darlene · 350 shares
- 0 days before the 2025-10-30 print — 2025-10-30 · S · Noci Darlene · 1,170 shares
Interval to Nuvalent, Inc.’s next reported results date
How the interval and sources are counted →
- 33within 5 days
- 88within 10 days
- 0shortest, days
- 26no later print
- Porter James Richard 2025-02-18 · S · 9 days before the 2025-02-27 print · President and CEO
- Porter James Richard 2025-02-18 · S · 9 days before the 2025-02-27 print · President and CEO
- Shair Matthew 2025-02-24 · S · 3 days before the 2025-02-27 print
- Shair Matthew 2025-02-24 · S · 3 days before the 2025-02-27 print
- Shair Matthew 2025-02-24 · S · 3 days before the 2025-02-27 print
- Noci Darlene 2025-04-29 · S · 9 days before the 2025-05-08 print · Chief Development Officer
- Noci Darlene 2025-07-30 · S · 8 days before the 2025-08-07 print · Chief Development Officer
- Pelish Henry E. 2025-08-07 · S · 0 days before the 2025-08-07 print · Chief Scientific Officer
- Miller Deborah Ann 2025-10-20 · S · 10 days before the 2025-10-30 print · Chief Legal Officer
- Shair Matthew 2025-10-27 · S · 3 days before the 2025-10-30 print
- Shair Matthew 2025-10-27 · S · 3 days before the 2025-10-30 print
- Shair Matthew 2025-10-28 · S · 2 days before the 2025-10-30 print
- Shair Matthew 2025-10-28 · S · 2 days before the 2025-10-30 print
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
- Miller Deborah Ann 2025-10-30 · S · 0 days before the 2025-10-30 print · Chief Legal Officer
Adoption dates Nuvalent, Inc. states
- 2023-12-06 in 14 filings
- 2023-12-21 in 2 filings
- 2024-04-02 in 10 filings
- 2024-11-01 in 6 filings
- 2024-11-18 in 29 filings
- 2024-11-20 in 2 filings
- 2024-12-12 in 7 filings
- 2025-12-04 in 5 filings
- 2025-12-11 in 2 filings
- 2025-12-23 in 5 filings
Filing text: “10b5-1 sell-to-cover instruction letter entered into on December 6, 2023”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-01-14
- 2026-02-26
- 2026-05-07
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.